Parkinson’s Therapies Expand Beyond Single Pathologies to Target Inflammation and Coexisting Conditions
Parkinson’s disease has long been described through a familiar biological storyline: abnormal accumulation of alpha-synuclein, progressive loss of dopamine-producing neurons ...
